155 related articles for article (PubMed ID: 16328405)
1. In vitro efficacy of the successive or staggered use of eardrops.
Kalcioglu MT; Ozturan O; Durmaz R; Aktas E
Eur Arch Otorhinolaryngol; 2006 May; 263(5):395-8. PubMed ID: 16328405
[TBL] [Abstract][Full Text] [Related]
2. Treatment of chronic suppurative otitis media with topical tobramycin and dexamethasone.
Alper CM; Dohar JE; Gulhan M; Ozunlu A; Bagger-Sjobak D; Hebda PA; Swarts JD
Arch Otolaryngol Head Neck Surg; 2000 Feb; 126(2):165-73. PubMed ID: 10680867
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo antimicrobial activity of topical ofloxacin and other ototopical agents.
Klein JO
Pediatr Infect Dis J; 2001 Jan; 20(1):102-3; discussion 120-2. PubMed ID: 11176586
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of topical ciprofloxacin and tobramycin in combination with dexamethasone in the treatment of chronic suppurative otitis media].
Kaygusuz I; Karlidağ T; Gök U; Yalçin S; Keleş E; Demirbağ E; Kaygusuz TO
Kulak Burun Bogaz Ihtis Derg; 2002; 9(2):106-11. PubMed ID: 12122630
[TBL] [Abstract][Full Text] [Related]
5. Comparative antibacterial activity of topical antiseptic eardrops against methicillin-resistant Staphylococcus aureus and quinolone-resistant Pseudomonas aeruginosa.
Youn CK; Jang SJ; Jo ER; Choi JA; Sim JH; Cho SI
Int J Pediatr Otorhinolaryngol; 2016 Jun; 85():80-3. PubMed ID: 27240501
[TBL] [Abstract][Full Text] [Related]
6. Bacterial profile and antimicrobial susceptibility patterns in chronic suppurative otitis media at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia.
Molla R; Tiruneh M; Abebe W; Moges F
BMC Res Notes; 2019 Jul; 12(1):414. PubMed ID: 31307545
[TBL] [Abstract][Full Text] [Related]
7. Assessment of antibacterial activity of some topical otological solutions.
Uçüncü H; Aktaş AE; Yazgi H; Yiğit N; Aktan B; Sütbeyaz Y
Kulak Burun Bogaz Ihtis Derg; 2005; 14(5-6):97-100. PubMed ID: 16340276
[TBL] [Abstract][Full Text] [Related]
8. A randomised controlled trial of active chronic otitis media comparing courses of eardrops versus one-off topical treatments suitable for primary, secondary and tertiary healthcare settings.
Loock JW
Clin Otolaryngol; 2012 Aug; 37(4):261-70. PubMed ID: 22804826
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of ofloxacin and its combination with dexamethasone in chronic suppurative otitis media. A randomised, double blind, parallel group, comparative study.
Panchasara A; Singh A; Mandavia D; Jha S; Tripathi C
Acta Otorhinolaryngol Ital; 2015 Feb; 35(1):39-44. PubMed ID: 26015650
[TBL] [Abstract][Full Text] [Related]
10. Microbiological profile with antibiotic sensitivity pattern of cholesteatomatous chronic suppurative otitis media among children.
Madana J; Yolmo D; Kalaiarasi R; Gopalakrishnan S; Sujatha S
Int J Pediatr Otorhinolaryngol; 2011 Sep; 75(9):1104-8. PubMed ID: 21715027
[TBL] [Abstract][Full Text] [Related]
11. [Microorganisms isolated from middle ear cultures and their antibacterial susceptibility in patients with chronic suppurative otitis media].
Gül HC; Kurnaz A; Turhan V; Oncül O; Pahsa A
Kulak Burun Bogaz Ihtis Derg; 2006; 16(4):164-8. PubMed ID: 16905907
[TBL] [Abstract][Full Text] [Related]
12. Emergence of ciprofloxacin-resistant pseudomonas in chronic suppurative otitis media.
Jang CH; Park SY
Clin Otolaryngol Allied Sci; 2004 Aug; 29(4):321-3. PubMed ID: 15270816
[TBL] [Abstract][Full Text] [Related]
13. ["In vitro" determination of bacterial sensitivity to tobramycin (author's transl)].
Talon D; Michel-Briand Y
Pathol Biol (Paris); 1976 Jan; 24(1):25-30. PubMed ID: 817253
[TBL] [Abstract][Full Text] [Related]
14. [Local treatment of purulent chronic otitis media with ciprofloxacin].
Podoshin L; Brodzki A; Fradis M; Ben-David J; Larboni J; Srugo I
Harefuah; 1998 Jan; 134(1):32-6, 78. PubMed ID: 9517277
[TBL] [Abstract][Full Text] [Related]
15. Topical ciprofloxacin/dexamethasone superior to oral amoxicillin/clavulanic acid in acute otitis media with otorrhea through tympanostomy tubes.
Dohar J; Giles W; Roland P; Bikhazi N; Carroll S; Moe R; Reese B; Dupre S; Wall M; Stroman D; McLean C; Crenshaw K
Pediatrics; 2006 Sep; 118(3):e561-9. PubMed ID: 16880248
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of ototopical drops against middle ear pathogens.
Ikeda K; Takasaka T
Am J Otol; 1993 Mar; 14(2):170-1. PubMed ID: 8389100
[TBL] [Abstract][Full Text] [Related]
17. The antibacterial activity of acetic acid and Burow's solution as topical otological preparations.
Thorp MA; Kruger J; Oliver S; Nilssen EL; Prescott CA
J Laryngol Otol; 1998 Oct; 112(10):925-8. PubMed ID: 10211213
[TBL] [Abstract][Full Text] [Related]
18. Chronic suppurative otitis media in cleft palate: microorganism etiology and susceptibilities.
Weckwerth PH; de Magalhães Lopes CA; Duarte MA; Weckwerth AC; Martins CH; Neto DL; de Aguiar HF
Cleft Palate Craniofac J; 2009 Sep; 46(5):461-7. PubMed ID: 19929097
[TBL] [Abstract][Full Text] [Related]
19. The development of antibiotic resistant organisms with the use of ototopical medications.
Weber PC; Roland PS; Hannley M; Friedman R; Manolidis S; Matz G; Owens F; Rybak L; Stewart MG
Otolaryngol Head Neck Surg; 2004 Mar; 130(3 Suppl):S89-94. PubMed ID: 15054367
[TBL] [Abstract][Full Text] [Related]
20. Clinical need for ototopical fluoroquinolones outweighs miniscule risk of antibiotic resistance.
Couzos S; Councillor H
J Paediatr Child Health; 2006 Apr; 42(4):223-4. PubMed ID: 16630330
[No Abstract] [Full Text] [Related]
[Next] [New Search]
